20% of hospitalized severe COVID-19 patients have kidney damage, Philippines detects a case of Omicron’s BA.5 subline
To date, more than 534.93 million people have contracted COVID-19 globally. (Photo: AP)
The country most severely affected by the epidemic COVID-19, America currently recorded over 86.46 million cases and more than 1,033 million deaths. In the past day, the US recorded more than 11,200 more people SARS-CoV-2 virus infection.
The White House plans to officially start giving the COVID-19 vaccine to children under the age of 5 as early as June 21, if it is approved by the federal agency in the coming weeks. The White House Coordinator for the COVID-19 response, Ashish Jha, said that the US has prepared enough COVID-19 vaccines from Pfizer and Moderna to start the vaccination program for young children when approved by authorities. through the. In which, the federal government will provide 10 million doses of vaccine to states and localities to launch an expanded vaccination campaign for children under 5 years old.
Vaccines made by Novavax (USA) have been licensed for use in many countries around the world, especially Europe, to prevent COVID-19. However, in the context of experts considering the use of this vaccine in the US, the US Food and Drug Administration (FDA) has expressed concern about the risk. Myocarditis after vaccination of Novavax.
An independent committee was convened at the request of the FDA to evaluate data from clinical trials of the COVID-19 vaccine manufactured by Novavax and make recommendations on the vaccine. On June 3, the FDA released a document analyzing the results of the evaluation, as it did for three other COVID-19 vaccines before being licensed for domestic use, which mentioned The risk of myocarditis after vaccination of Novavax.
The discovery of multiple cases of myocarditis after vaccination among the 40,000 people participating in the clinical trial has raised concerns that the risk of myocarditis from Novavax’s vaccine may be higher than that of the Novavax vaccine, according to the FDA, according to the FDA. risks from other vaccines like Pfizer or Moderna. Previously, experts have also identified a low risk of myocarditis after vaccination against COVID-19 made by Pfizer or Moderna, especially in young men.
At the world’s second largest COVID-19 epidemic center Indiaon June 4, the country recorded a total of over one million people with COVID-19, including more than one death from COVID-19.
India has approved the use of Biological E’s COVID-19 vaccine as a booster shot for people who have received a basic dose of other vaccines. This is the first time this country allows the combination of vaccines as booster shots. In an announcement on June 4, Biological E said that the Medicines Regulatory Authority of India (DCGI) has approved the use of Corbevax vaccine as a booster for people 18 years of age and older who have received 2 doses of Covishield vaccine. by AstraZeneca and Covaxin by Bharat Biotech.
India has administered more than 1.87 billion shots in a bid to give two shots of the vaccine to people 12 years of age and older.
Brazil Currently, it is the world’s third largest epidemic hotspot with more than COVID-19 patients out of a total of over one million infected people in this country.
Brazil will give a fourth dose of the COVID-19 vaccine to people over the age of 50. (Photo: AP)
Brazil’s Health Ministry has approved a proposal for a fourth dose of the COVID-19 vaccine for people over the age of 50 to strengthen their ability to prevent a resurgence of the disease. According to the announcement of Brazilian Health Minister Marcelo Queiroga, this second booster vaccine will be given at least 4 months after the first booster and vaccines will be applied including Pfizer, Janssen or AstraZeneca. In mid-May, Brazilian health authorities also approved the application of a fourth dose of the vaccine to all people over 60 years old.
The state of medical emergency declared by the Brazilian federal government after the outbreak of COVID-19 in early 2020 was officially declared to end on May 22. However, the Sao Paulo city government has advised people to use masks in public places with enclosed spaces, although this measure is not mandatory.
According to official statistics, up to now, 77.4% of the Brazilian population has completed the basic two-shot COVID-19 vaccine regimen.
Researchers Australia said that millions of COVID-19 patients around the world may have been undiagnosed at risk of deadly kidney disease. Severe kidney damage (AKI) occurs when the organ suddenly stops filtering the blood, sometimes leading to weakness or even death. This is often caused by complications of other serious illnesses.
University of Queensland PhD student and kidney specialist Marina Wainstein said that available figures show that around 20% of hospitalized patients with severe COVID-19 have AKI lesions and the number This is 40% for those in intensive care. The study results were published in the medical journal PLOS on June 3.
According to new research by scientists IsraelPfizer’s antiviral drug Paxlovid helps reduce hospitalization and death from COVID-19 in vaccinated and unvaccinated people 65 years of age and older. This study was conducted over a period of time Omicron variant of the SARS-CoV-2 virus that causes COVID-19 spreading in this country.
Research results show that Paxlovid reduces the risk of hospitalization by 86% for the elderly who are not immune, that is, have not been vaccinated or have never had COVID-19. The drug also works for people who already have immunity, but at a lower rate, only about 60%.
Ministry of Health Philippines (DOH) reported that 2 cases were detected sub-lineage infection BA.5 of the Omicron variant that causes COVID-19 in this country. These two cases are members of the same family in a province north of Manila.
Speaking at an online press conference, Philippine Deputy Health Minister Maria Rosario Vergeire confirmed that the BA.5 variant was detected on May 15 in the patient samples of the two cases mentioned above. These two people have all received the basic dose and booster dose of the COVID-19 vaccine. Both currently live in the Luzon region, central Philippines and have not traveled before.
In addition to BA.5, so far, the Philippines has also detected two other sublines of the Omicron variant, BA.2.12.1 and BA.4.
The Philippines has recorded 2 cases of infection with the BA.5 subline of the Omicron variant. (Photo: AP)
A study in Japan Studies have shown that women have a higher risk of side effects such as rashes than men after receiving the first dose of Moderna’s COVID-19 vaccine. The above study involved 5,893 volunteers and was carried out from May to November 2021. The results showed that 22.4% of women participating in the study had a slow skin reaction after the first dose of the vaccine, while this rate in men was 5.1%. According to the report, published June 1 in the Journal of the American Medical Association, people who experience side effects have mild symptoms and are not considered contraindications to the mRNA technology vaccine.
According to the study team author from Tokyo Self-Defense Forces Central Hospital, delayed skin reactions occur during or after 6 days of injection and have been reported as a rare side effect in the US as well as in Europe. The researchers also found that Japan recorded a higher rate of delayed skin reactions after receiving the COVID-19 vaccine, possibly because people here have a higher awareness of this symptom. The scientists also suggest that the higher incidence of hives in women is likely due to differences in weight as well as hormonal and environmental factors.
China adopted more stringent criteria in monitoring nucleic acid testing for COVID-19 detection. According to a circular issued by the Coordination Office for COVID-19 Prevention and Control under the State Council, local governments in China are required to continue to implement relevant regulations on capacity assessment of agencies. testing, tightening the inspection of agencies and personnel. The document also emphasizes the need to standardize the management of specimen collection, storage and transport, including personnel training, and notes the need for increased ongoing monitoring. to continuously improve test quality.
The circular also sets out specific requirements for the monitoring of large-scale nucleic acid testing, nucleic acid testing resources and contingency mechanisms for testing organizations.
China has declared success in controlling the COVID-19 outbreak in the city of Shanghai when it recorded the fewest new cases in more than 3 months.
Special administrative region government Hong Kong (China) on June 4 said it would distribute about 100,000 rapid antigen test kits for the SARS-CoV-2 virus to people in some areas to trace COVID-19 cases. Previously, authorities still detected SARS-CoV-2 virus in wastewater samples of these areas.
Test kits will be distributed to residents, sanitation workers and property managers in the areas of Kwun Tong and Wong Tai Sin, where wastewater test results show a high viral load. . The Hong Kong government urges those who use the test kit if they have a positive result to promptly report it through the online platforms of the authorities.
In response to the current wave of COVID-19 epidemic, the Environmental Protection and Sewerage Service in Hong Kong has stepped up the testing of wastewater samples in all areas of the special zone.
Regarding the situation of COVID-19 epidemic, on June 4, Hong Kong recorded 176 new cases of COVID-19 detected through nucleic acid testing and 270 cases were self-reported after rapid testing showed results. tested positive for the SARS-CoV-2 virus.
According to the World Health Organization (WHO), more than two-thirds of the world’s population may already have significant levels of COVID-19 antibodies, meaning that they have had the disease or been vaccinated. In a compilation of studies from around the world, WHO said the proportion of the population with significant levels of COVID-19 antibodies increased from 16% in February 2021 to 67% in October 2021. . With the advent of the fast-spreading variant of Omicron, this rate may now be even higher.
Although the vaccine is only moderately protective against the Omicron variant, WHO still urges countries to increase vaccination rates, especially for people in high-risk groups, because immunity is thanks to vaccination. Vaccines are more effective at preventing disease progression than immunity acquired after a previous infection.
* Invite readers to watch programs broadcast by Vietnam Television on TV Online and VTVGo!
at Blogtuan.info – Source: vtv.vn – Read the original article here